HAE Haemonetics Corporation

NYSE
$105.30

Haemonetics Corporation (HAE) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $1.30 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +22.8% since its last earnings release on August 6, 2026.

Haemonetics Beat Consensus Estimates
Thursday, August 6, 2026 · 6:00 AM ET
Earnings Date
2nd Quarter, Sep 2026
Nov 6
Friday · 6:00 AM ET
Earnings Whisper
-
vs $1.30
Rev est $346.84M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $101.56

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Haemonetics Corporation

Haemonetics Corp is a healthcare company that provides blood management solutions to its customers. It serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.